Peptide Library

In clinical trials

Immune & defense

Murepavadin

Evidence

Clinical trials

Class

Antibacterial peptidomimetic

/

Murepavadin

KEY TAKEAWAY

Murepavadin is a synthetic cyclic peptide designed to kill Pseudomonas aeruginosa by blocking a protein the bacterium needs to build its outer membrane. Murepavadin is not FDA-approved. Phase 3 trials of the intravenous form were halted because of kidney toxicity, and an inhaled version has been in development.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Antibacterial peptidomimetic

Being studied for

Studied for Pseudomonas pneumonia

Key fact

Murepavadin is not FDA-approved. Phase 3 trials of the intravenous form were halted because of kidney toxicity, and an inhaled version has been in development.

Route

Intravenous in earlier trials; inhaled in development

Evidence strength

Clinical trials

What it is

What it is

Murepavadin is a synthetic cyclic peptide designed to kill Pseudomonas aeruginosa by blocking a protein the bacterium needs to build its outer membrane.

How it works

How it works

It binds LptD, a transporter that places lipopolysaccharide in the bacterial outer membrane, so the cell cannot maintain its protective shell.

Regulatory status

Regulatory status

Murepavadin is not FDA-approved. Phase 3 trials of the intravenous form were halted because of kidney toxicity, and an inhaled version has been in development.

What it is used for

What it is used for

Studied for Pseudomonas pneumonia.

Side effects and risks

Side effects and risks

The intravenous form caused kidney injury in trials.

Citations

Citations

Murepavadin: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo